7DUO
Crystal structure of daratumumab fab and CD38 complex
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U |
Synchrotron site | SSRF |
Beamline | BL17U |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2020-09-16 |
Detector | DECTRIS EIGER2 X 16M |
Wavelength(s) | 0.9798 |
Spacegroup name | P 1 2 1 |
Unit cell lengths | 81.611, 54.658, 93.052 |
Unit cell angles | 90.00, 98.16, 90.00 |
Refinement procedure
Resolution | 46.055 - 2.810 |
Rwork | 0.231 |
R-free | 0.23760 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1yh3 |
Data reduction software | HKL-2000 |
Data scaling software | HKL-2000 |
Phasing software | PHENIX |
Refinement software | PHENIX (1.14_3260) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 50.000 | 2.900 |
High resolution limit [Å] | 2.810 | 2.810 |
Rmerge | 0.183 | 0.183 |
Number of reflections | 19416 | 19416 |
<I/σ(I)> | 12.18 | |
Completeness [%] | 100.0 | |
Redundancy | 6.4 | |
CC(1/2) | 0.969 | 0.969 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | EVAPORATION, RECRYSTALLIZATION | 291 | 0.2M Sodium phosphate monobasic monohydrate, 20% w/v Polyethylene glycol 3350 |